Hsing-Jien Kung
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research 15
- Cancer, Hypoxia, and Metabolism 15
- Oncology top 1%
- Viral-associated cancers and disorders 19
- Molecular Biology top 0.5%
- Ubiquitin and proteasome pathways 11
- RNA modifications and cancer 10
- Virology top 2%
- Immunology top 1%
-
- Herpesvirus Infections and Treatments 26
- Cytomegalovirus and herpesvirus research 25
-
- Prostate Cancer Treatment and Research 23
- Co-authors
- Yun QiuClifford G. TepperYoshihiro IzumiyaChristopher P. EvansHong-Wu ChenDavid K. AnnDan R. RobinsonAi-Hong Ma
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Hsing-Jien Kung
142 papers receiving 10.8k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 3.0k
- Oncology 2.5k
- Molecular Biology 6.2k
- Virology 380
- Immunology 1.6k
Countries citing papers authored by Hsing-Jien Kung
This map shows the geographic impact of Hsing-Jien Kung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing-Jien Kung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing-Jien Kung more than expected).
Fields of papers citing papers by Hsing-Jien Kung
This network shows the impact of papers produced by Hsing-Jien Kung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing-Jien Kung. The network helps show where Hsing-Jien Kung may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hsing-Jien Kung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2021 | 7 | |
| 3 | 2020 | 38 | |
| 4 | 2019 | 19 | |
| 5 | 2016 | 54 | |
| 6 | 2015 | 61 | |
| 7 | 2014 | 19 | |
| 8 | 2010 | 91 | |
| 9 | 2010 | 5 | |
| 10 | A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growthbreakdown → | 2009 | 698 |
| 11 | 2008 | 67 | |
| 12 | 2008 | 57 | |
| 13 | 2007 | 390 | |
| 14 | 2006 | 43 | |
| 15 | 2006 | 49 | |
| 16 | 2005 | 16 | |
| 17 | 2004 | 25 | |
| 18 | 2004 | 31 | |
| 19 | 2000 | 117 | |
| 20 | 1999 | 54 |
About Hsing-Jien Kung
Hsing-Jien Kung is a scholar working on Cancer Research, Virology and Oncology, having authored 143 papers that have together received 11.1k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (26 papers), Cytomegalovirus and herpesvirus research (25 papers), Prostate Cancer Treatment and Research (23 papers), Viral-associated cancers and disorders (19 papers), Cancer-related molecular mechanisms research (15 papers), Cancer, Hypoxia, and Metabolism (15 papers), Ubiquitin and proteasome pathways (11 papers) and RNA modifications and cancer (10 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (2.5k citations) and Molecular Biology (6.2k citations). Hsing-Jien Kung has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Yun Qiu, Clifford G. Tepper, Yoshihiro Izumiya, Christopher P. Evans, Hong-Wu Chen, David K. Ann, Dan R. Robinson, Ai-Hong Ma, Joy C. Yang and L. B. Crittenden. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.